- Home
- DNN vs SNDX Comparison
DNN vs SNDX Comparison
Compare DNN & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNN
- SNDX
- Stock Information
- Founded
- DNN 1936
- SNDX 2005
- Country
- DNN Canada
- SNDX United States
- Employees
- DNN N/A
- SNDX N/A
- Industry
- DNN Other Metals and Minerals
- SNDX Biotechnology: Pharmaceutical Preparations
- Sector
- DNN Basic Materials
- SNDX Health Care
- Exchange
- DNN Nasdaq
- SNDX Nasdaq
- Market Cap
- DNN 1.7B
- SNDX 1.6B
- IPO Year
- DNN 1997
- SNDX 2016
- Fundamental
- Price
- DNN $2.38
- SNDX $16.09
- Analyst Decision
- DNN Strong Buy
- SNDX Strong Buy
- Analyst Count
- DNN 2
- SNDX 11
- Target Price
- DNN $3.00
- SNDX $37.18
- AVG Volume (30 Days)
- DNN 22.0M
- SNDX 2.3M
- Earning Date
- DNN 11-07-2024
- SNDX 11-05-2024
- Dividend Yield
- DNN N/A
- SNDX N/A
- EPS Growth
- DNN N/A
- SNDX N/A
- EPS
- DNN N/A
- SNDX N/A
- Revenue
- DNN $2,920,167.00
- SNDX $16,000,000.00
- Revenue This Year
- DNN $218.60
- SNDX N/A
- Revenue Next Year
- DNN $212.20
- SNDX $219.92
- P/E Ratio
- DNN N/A
- SNDX N/A
- Revenue Growth
- DNN N/A
- SNDX N/A
- 52 Week Low
- DNN $1.40
- SNDX $15.00
- 52 Week High
- DNN $2.47
- SNDX $25.34
- Technical
- Relative Strength Index (RSI)
- DNN 65.15
- SNDX 37.58
- Support Level
- DNN $2.02
- SNDX $15.00
- Resistance Level
- DNN $2.20
- SNDX $16.27
- Average True Range (ATR)
- DNN 0.13
- SNDX 1.08
- MACD
- DNN 0.02
- SNDX -0.36
- Stochastic Oscillator
- DNN 95.35
- SNDX 14.53
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company with interests focused in the Athabasca Basin region of northern Saskatchewan, Canada. The company has an effective 95% interest in its flagship Wheeler River Uranium Project, which is the largest undeveloped uranium project in the infrastructure-rich eastern portion of the Athabasca Basin region of northern Saskatchewan. The company is also engaged in mine decommissioning and environmental services through its Closed Mines group, which manages its Elliot Lake reclamation projects and provides third-party post-closure mine care and maintenance services.
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.